gefitinib has been researched along with emodin in 2 studies
| Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (emodin) | Trials (emodin) | Recent Studies (post-2010) (emodin) |
|---|---|---|---|---|---|
| 5,231 | 566 | 2,919 | 1,792 | 3 | 1,102 |
| Protein | Taxonomy | gefitinib (IC50) | emodin (IC50) |
|---|---|---|---|
| Chain A, PROTEIN KINASE CK2, ALPHA SUBUNIT | Zea mays | 1 | |
| Protein tyrosine phosphatase type IVA 3 | Homo sapiens (human) | 3.5 | |
| Estrogen receptor | Homo sapiens (human) | 2.7 | |
| Cytochrome P450 1A2 | Homo sapiens (human) | 3.73 | |
| Heme oxygenase 1 | Rattus norvegicus (Norway rat) | 1.22 | |
| Serine/threonine-protein kinase pim-1 | Homo sapiens (human) | 2.5 | |
| Aldo-keto reductase family 1 member B1 | Homo sapiens (human) | 2.69 | |
| Casein kinase II subunit alpha' | Homo sapiens (human) | 1.04 | |
| Proteasome subunit beta type-1 | Homo sapiens (human) | 0.24 | |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | 4.32 | |
| Amine oxidase [flavin-containing] B | Homo sapiens (human) | 3.24 | |
| Proteasome subunit beta type-5 | Homo sapiens (human) | 1.22 | |
| Casein kinase II subunit beta | Homo sapiens (human) | 0.8667 | |
| Casein kinase II subunit alpha | Homo sapiens (human) | 1.0112 | |
| Estrogen receptor beta | Homo sapiens (human) | 5.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balsari, A; Campiglio, M; Castiglioni, F; Ménard, S; Pupa, SM; Tagliabue, E | 1 |
| Chen, RS; Cheng, CM; Chuang, SM; Ciou, SC; Jhan, JY; Ko, JC; Lee, WT; Lin, ST; Lin, YW; Su, YJ | 1 |
2 other study(ies) available for gefitinib and emodin
| Article | Year |
|---|---|
Role of exon-16-deleted HER2 in breast carcinomas.
Topics: 3T3 Cells; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Proliferation; Cells, Cultured; Drug Tolerance; Emodin; Enzyme Inhibitors; ErbB Receptors; Exons; Flow Cytometry; Gefitinib; Gene Expression Regulation, Neoplastic; Humans; Kidney; Mice; Mice, Inbred BALB C; Mice, Nude; Polymerase Chain Reaction; Quinazolines; Receptor, ErbB-2; RNA Splicing; Trastuzumab | 2006 |
Emodin enhances gefitinib-induced cytotoxicity via Rad51 downregulation and ERK1/2 inactivation.
Topics: Animals; Antineoplastic Agents; Apoptosis; Butadienes; Cell Line, Tumor; Emodin; Gefitinib; Humans; MAP Kinase Kinase 1; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Nitriles; Proteasome Endopeptidase Complex; Protein Kinase Inhibitors; Quinazolines; Rad51 Recombinase; RNA, Small Interfering; Signal Transduction | 2009 |